Lantern Pharma: Redefining Oncology Drug Development with A.I. and Machine Learning
Lantern Pharma (NASDAQ: LTRN) is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Our proprietary AI and machine learning (ML) platform, RADR®, leverages over 25 billion oncology-focused data points and a library of 200+ advanced ML algorithms to help solve billion-dollar, real-world problems in oncology drug development. By harnessing the power of AI and with input from world-class scientific advisors and collaborators, we have accelerated the development of our growing pipeline of therapies including eleven cancer indications and an antibody-drug conjugate (ADC) program. On average, our newly developed drug programs have been advanced from initial AI insights to first-in-human clinical trials in 2-3 years and at approximately $1.0-2.0 million per program. Visit LTRNinfo.com to learn more.
-
LIVE
Game On!
1 hour agoIt's Feel Good Friday! Get In Here! | Sports Afternoon Espresso Shot
185 watching -
UPCOMING
Battleground with Sean Parnell
3 hours agoTarget: We the People
450 -
40:34
TudorDixon
3 hours agoEXCLUSIVE: Tudor's Interview with Lunden Roberts | The Tudor Dixon Podcast
2211 -
1:01:21
Lee Camp
3 hours agoBREAKING: 175,000 Weed Convictions Pardoned + Abortion Pill Still Legal!
7.32K -
1:10:17
Twins Pod
22 hours agoWhat The HELL is Going On With Infowars? | Twins Pod - Episode 18 - Chase Geiser
43K20 -
LIVE
Revenge of the Cis
1 hour agoTribulation (Apocalypse III) Movie Riff
299 watching -
13:37
ErmzPlays
2 hours agoThe Witcher Has Finally Been Put Out Of Its Misery
2.18K -
1:01:30
The Quartering
3 hours agoTrump Raises Massive Funds, OnlyFans Backfire, Dana White Torches Cancel Culture
23.8K29 -
7:06
KFC Radio Clips
4 hours agoShane Gillis Tells Us His Worse First Date Story
26.1K8 -
59:42
Ben Shapiro
5 hours agoEp. 1989 - The Debate Is COMING
52.2K90